John Militello - 21 Apr 2023 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role: VP, Principal Accounting Officer and Interim Principal Financial Officer
Signature: /s/ Martin Wilson, as attorney-in-fact for John Militello
Issuer symbol: RCKT
Transactions as of: 21 Apr 2023
Net transactions value: -$43,678
Form type: 4
Filing time: 25 Apr 2023, 18:33:13 UTC
Previous filing: 20 Apr 2023
Next filing: 16 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCKT	Common Stock	Sale	$43,678	-2,342	-29%	$18.65	5,636	21 Apr 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs received by the Reporting Person.
F2	This transaction was executed in multiple brokered trades at prices ranging from $18.55 to $18.88. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

VP, Principal Accounting Officer and Interim Principal Financial Officer